Background and purpose The treatment of community-acquired pneumonia (CAP) is
complicated by the growing threat of antimicrobial resistance and the tendency to rely on …

BACKGROUND: There has not been a comprehensive multi-center study investigating the
microbial profile of community acquired pneumonia (CAP) in Taiwan. METHODS: A …

The aim of this multicenter study was to identify the causative pathogens of community-
acquired pneumonia (CAP) in Shanghai, China, and to determine their susceptibility to …

Study objectives: To determine microbial agents causing community-acquired pneumonia
(CAP) in Southeast Asia. Design: A prospective study. Setting: Three general hospitals in …

Background Successful therapy for community-acquired pneumonia (CAP) requires
appropriate empirical antimicrobial therapy based on the local microbe and resistance …

Local epidemiological data on the etiologies of in-patients who are hospitalized with CAP is
needed to develop guidelines for clinical practice. This study was conducted to determine …

Objective Knowledge about the etiology of community-acquired pneumonia (CAP) is
essential for adequate management. Presently, few studies about CAP are available from …

Background Appropriate antimicrobial therapy of community-acquired pneumonia (CAP) is
mainly based on the distribution of etiology and antimicrobial resistance of major pathogens …

Objective To investigate the pathogenic causes of community-acquired pneumonia (CAP) in
adult patients in China, the relation of previous antibiotic use and the Pneumonia Patient …

Most patients with community-acquired pneumonia are treated as out-patients with empirical
therapy, since initially the etiologic agent is unknown. We prospectively assessed the …